Prothena Corporation plc - Ordinary Shares (NQ:PRTA)

8.270 -0.090 (-1.08%)

Delayed Quote Updated: 4:00 PM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Prothena Corporation plc - Ordinary Shares

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Analyst Expectations for Prothena Corp's Future ↗

December 21, 2022

Via Benzinga

Cantor Fitzgerald Maintains Overweight Rating for Prothena Corp: Here's What You Need To Know ↗

December 21, 2022

Via Benzinga

Prothena Announces Pricing of Public Offering of 3,250,000 Ordinary Shares

December 14, 2022

From Prothena Corporation plc

Via Business Wire

Why Prothena Shares Are Trading Lower ↗

December 14, 2022

Prothena Corporation PLC (NASDAQ: PRTA) shares are trading lower by 6.53% to $59.10 during Wednesday morning. The company announced that it has commenced an underwritten public offering of 3,000,000 of...

Via Benzinga

Why Prothena Shares Are Nosediving During Tuesday's After-Hours Session ↗

December 13, 2022

Prothena Corporation PLC (NASDAQ: PRTA) shares are trading lower by some 8.35% to $57.95 during Tuesday's after-hours session. The company announced that it has commenced an underwritten public...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

December 13, 2022

Via Benzinga

What 4 Analyst Ratings Have To Say About Prothena Corp ↗

November 04, 2022

Within the last quarter, Prothena Corp (NASDAQ:PRTA) has observed the following analyst ratings:

Via Benzinga

Recap: Prothena Corp Q3 Earnings ↗

November 03, 2022

Prothena Corp (NASDAQ:PRTA) reported its Q3 earnings results on Thursday, November 3, 2022 at 04:00 PM. Here's what investors need to know about the announcement.

Via Benzinga

Prothena Announces Proposed Public Offering of Ordinary Shares

December 13, 2022

From Prothena Corporation plc

Via Business Wire

Prothena Presents Data Demonstrating Consistent Survival Benefit Observed with Birtamimab in Mayo Stage IV AL Amyloidosis Patients in Phase 3 VITAL Study at ASH 2022

December 12, 2022

From Prothena Corporation plc

Via Business Wire

10 Health Care Stocks Whale Activity In Today's Session ↗

November 22, 2022

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...

Via Benzinga

Prothena Announces Achievement of $40 Million Clinical Milestone Payment from Novo Nordisk for PRX004/NNC6019 Under Investigation for the Treatment of ATTR Cardiomyopathy

November 21, 2022

From Prothena Corporation plc

Via Business Wire

Roche's Alzheimer's Drug Fails In Phase 3; Here's The Fallout For Biogen, Lilly, Prothena And Others ↗

November 14, 2022

Biogen rose on Roche's Alzheimer's failure as a potential competitor drops off the map.

Via Investor's Business Daily

Prothena Reports Third Quarter 2022 Financial Results and Business Highlights

November 03, 2022

From Prothena Corporation plc

Via Business Wire

Prothena to Present Data on Survival Benefit Observed in Completed Phase 3 Study of Drug Candidate Birtamimab in Patients with Mayo Stage IV AL Amyloidosis at the ASH 2022 Meeting

November 03, 2022

From Prothena Corporation plc

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For November 4, 2022 ↗

November 04, 2022

Upgrades

Via Benzinga

Earnings Preview: Prothena Corp ↗

November 02, 2022

Prothena Corp (NASDAQ:PRTA) is set to give its latest quarterly earnings report on Thursday, 2022-11-03. Here's what investors need to know before the announcement. Analysts estimate that Prothena Corp...

Via Benzinga

As Small Caps Rally, These 3 Finance High-Yielders Could Have Further Upside ↗

October 28, 2022

In the past month with the Russell 2000 index up roughly 7%, as compared to the S&P 500 index up nearly 4.8%, it is evident that small cap stocks are leading the charge in this bear market rally. The...

Via Benzinga

Prothena to Report Third Quarter 2022 Financial Results on November 3rd

October 27, 2022

From Prothena Corporation plc

Via GlobeNewswire

Alzheimer’s Pipeline of New Treatments Race to Improve Quality of Life for Patients

October 20, 2022

Palm Beach, FL – October 20, 2022 – FinancialNewsMedia.com News Commentary – Last year, about 6.2 million people aged 65 and above living in America were suffering from Alzheimer’s disease, (AD) which...

Via FinancialNewsMedia

Netflix, Biogen And Other Big Gainers From Wednesday ↗

September 29, 2022

U.S. stocks closed higher with the Dow Jones surging more than 500 points on Wednesday. Here is the list of some big stocks recording gains in the previous session.

Via Benzinga

Why NLS Pharmaceutics Shares Tumbled Over 66%; Here Are 68 Biggest Movers From Yesterday ↗

September 29, 2022

Gainers PepGen Inc. (NASDAQ: PEPG) jumped 110.2% to close at $10.93 after the company announced results from its Phase 1 healthy volunteer trial of PGN-EDO51 for Duchenne Muscular Dystrophy. The trial...

Via Benzinga

These Stocks Are On The Radar After Biogen-Eisai's Surprising Alzheimer's Trial Win ↗

September 28, 2022

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

September 28, 2022

Gainers

Via Benzinga

LVWR Stock Alert: 7 Things to Know as LiveWire Starts Trading ↗

September 28, 2022

LiveWire (LVWR) stock is in the news Wednesday as the electric motorcycle company makes its trading debut today after a SPAC merger.

Via InvestorPlace

Why Is Prothena (PRTA) Stock Up 75% Today? ↗

September 28, 2022

Prothena (PRTA) stock is seeing massive gains on Wednesday despite a lack of recent news from the late-stage clinical company.

Via InvestorPlace

Stocks Take Another Stab At Rebound As Bond Yields Soften ↗

September 28, 2022

Stocks are making another attempt to rebound on Wednesday, with the Dow Jones Industrial Average and S&P 500 Index both up roughly 1% at the midway mark.

Via Talk Markets

How Is The Market Feeling About Prothena Corp? ↗

September 28, 2022

Prothena Corp's (NASDAQ:PRTA) short percent of float has fallen 8.23% since its last report. The company recently reported that it has 2.46 million shares sold short, which is 13.83% of all regular...

Via Benzinga

Why Prothena Corporation Shares Are Trading Higher By 76%, Here Are 53 Stocks Moving In Wednesday's Mid-Day Session ↗

September 28, 2022

Gainers

Via Benzinga

US Stocks Mixed; Wholesale Inventories Increase 1.3% In August ↗

September 28, 2022

U.S. stocks traded mixed this morning, with the Dow Jones gaining around 20 points on Wednesday.

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.